Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT00838643 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2009-02-09
Summary
Evaluation of incidence of invasive aspergillosis in patients who have undergone an allogeneic stem cell transplantation, with particular regard to the role of galactomannan assay and of early TC scan in asymptomatic patients.
Conditions
- Hematological Diseases
- Invasive Aspergillosis
Sponsors & Collaborators
-
Ospedale Santa Croce-Carle Cuneo
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-05-31
- Primary Completion
- 2007-06-30
- Completion
- 2009-12-31
Countries
- Italy
Study Locations
More Related Trials
-
IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE
NCT02023671 ·Status: UNKNOWN
-
B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation
NCT04682314 ·Status: UNKNOWN
-
Immunomonitoring After Hematopoietic Stem Cell Transplantation
NCT04635397 ·Status: ACTIVE_NOT_RECRUITING
-
Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation
NCT04737785 ·Status: COMPLETED
-
Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas
NCT00998361 ·Status: UNKNOWN ·Phase: PHASE2
-
Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France
NCT04282421 ·Status: COMPLETED
-
Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT
NCT04412811 ·Status: COMPLETED
-
Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant
NCT02088840 ·Status: COMPLETED
-
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
NCT02035189 ·Status: COMPLETED
-
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT01420172 ·Status: COMPLETED
-
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
NCT00813501 ·Status: TERMINATED
-
A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT
NCT05077150 ·Status: COMPLETED
-
Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience
NCT05088941 ·Status: COMPLETED
-
Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients
NCT07324291 ·Status: NOT_YET_RECRUITING
-
Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT00888316 ·Status: COMPLETED
-
Modification of the Human Colon and Oral Microbiome by Allogenic HSCT
NCT03942159 ·Status: UNKNOWN
-
Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion
NCT06639750 ·Status: NOT_YET_RECRUITING
-
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
NCT06904053 ·Status: RECRUITING
-
A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies
NCT02386332 ·Status: UNKNOWN
-
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
NCT00146055 ·Status: COMPLETED ·Phase: PHASE2
-
Pulmonary Complications of Hematopoietic Stem Cell Transplantation
NCT00837681 ·Status: COMPLETED
-
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets
NCT01687231 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Application of Donor-derived TCM After Allogeneic HSCT
NCT02758223 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey
NCT04469985 ·Status: COMPLETED
-
Origin of CEC in Patients After Allo-HSCT
NCT04038827 ·Status: COMPLETED